BrainVectis
Treat neurodegenerative diseases by restoring brain cholesterol metabolism
BrainVectis has raised €1.0M across 1 funding round, most recently a Series A round in Sep 2016. Based in Fontenay-aux-Roses, France; active in Healthtech. Data as of 28 Oct 2026.
Fontenay-aux-Roses, Francewww.brainvectis.com ↗
Total raised
€1.0M
€1,000,000
Funding rounds
1
Investors
0
distinct backers
Active since
2016-09
latest 2016-09
Funding by year
EUR raised per yearBrainVectis — funding by year — interactive chart.
Data table
| BrainVectis — funding by year | |
|---|---|
| 2016 | €1.0M |
Signals
Medium confidenceRaise-next likelihood9
base rate 44% for Series A
- ▼ Dormant (no round in 3+ cohort gaps)
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2016-09-01 | Series A | €1.0M | — | View deal → |
Related news
Similar companies
same sector or country- Mistral AI€6.5BFrance · AI
- Automotive Cells Company (ACC)€4.4BFrance · Transportation
- Philips€2.6BNetherlands · Healthtech
- Verkor€2.4BFrance · Energy
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
Global coverage: FundingData